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ABSTRACT
Osteoporosis is caused by caused by low bone mass, microarchitecture disruption and increase
in skeletal fragility (Rosen & Drezner, 2021). This disease presents as a silent disease without
any clinical manifestations and increases risk for bone fracture. The purpose of this EvidenceBased Practice (EBP) project was to increase screening rates for osteoporosis in the female
population by mailing a patient reminder letter to the home of qualifying patients in the primary
care setting and to determine if mailing a patient reminder letter would increase screening rates.
The Johns Hopkins Evidence-Based Practice for Nurses and Healthcare professionals (JHEBP)
model was used as a framework to guide the project for the 77 females at a small primary care
clinic in northern Indiana. After organizational approval of this EBP project, letter reminders
were created and mailed to those females who were 65 years and older and who did not have a
reported DXA screen on their electronic medical record. To determine if the mailed reminder
was effective, data was collected from the literature evidence pieces and then compared to the
post-intervention group data. The data was analyzed using the binomial test in an effort to
determine the effectiveness of the patient mailed reminder letter. Implications for practice to be
discussed.
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CHAPTER 1
INTRODUCTION
Background
Osteoporosis is a “silent” disease that is categorized by low bone mass, disruption of
microarchitecture, and increased skeletal fragility (Rosen & Drezner, 2021). Bone homeostasis is
dependent upon the formation of bone by osteoblasts and the resorption of bone by osteoclasts;
the imbalance of these tightly linked processes leads to osteoporosis (Chen et al., 2018). Bone is
constantly in the remodeling state and maintaining normal skeletal structure is important for
function. Any impaired remodeling process can create an imbalance of the bone leading to a
diagnosis of osteoporosis. Osteoporosis is considered a silent disease because there are no
clinical manifestations until there is a fragility fracture (National Osteoporosis Foundation [NOF],
2021a). Fractures at the hip, spine or wrist are the most common places this can occur (United
States Preventive Services Task Force [USPSTF], 2018). Chronic pain, limited mobility,
disability, deformity, depression and isolation can all result from a fracture.
A number of factors are related to osteoporosis: estrogen deficiency in post-menopausal
women (including advanced age), low body mass index, cigarette smoking, excessive alcohol
consumption, and prolonged glucocorticoid therapy (Rosen & Drezner, 2021). Given these risk
factors, it is not surprising to note that 54 million women in the United States have been
diagnosed with osteoporosis or osteopenia (USPSTF, 2018), and the annual number of fragility
fractures exceeds 2 million.
The overall costs related to osteoporosis have been estimated at $19 billion (USPSTF
2018). Healthcare plans pay an estimated mean of $34,855 per patient who experiences an
osteoporotic fracture (Williams et al., 2020). The economic burden associated with fractures
stresses the importance of early identification of “at risk” individuals with preventive care.
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Given the economic impact and knowledge of the underlying disease processes, the
USPSTF has developed recommendations for osteoporosis screening in women. Current
national guidelines recommend that all women age 65 years and older undergo a bone mineral
density (BMD) test to screen for osteoporosis, a Grade B recommendation (USPSTF, 2018).
Within their recommendation statement on screening for osteoporosis, the USPSTF (2018) has
noted that bone measurement tests are accurate for detecting osteoporosis and for forecasting
fractures in the population of women 65 years and older. Thus, BMD screening will help serve to
prevent osteoporotic fractures (USPSTF, 2018). With recommended preventative screening in
women, the US estimated osteoporosis associated cost of $25.3 billion annually will ideally
decrease (USPSTF, 2018).
Dual-energy x-ray absorptiometry (DXA) is the most common tool used for diagnosing
BMD of relevant skeletal sites (hip and spine) (USPSTF, 2021), and has a sensitivity of 88.2%
for detecting osteoporosis (Humadi et al., 2010). The DXA scan is noninvasive and can be done
at a local hospital. Within a DXA scan, dual energy photon beams distinguish between soft tissue
and quantify bone mineral density. Bone density is quantified by measuring bone mineral
content in grams and bone area in centimeters, then calculated by dividing bone mineral content
by bone area (Lewiecki, 2021). The calculated BMD is represented by T-score which analyzes
an individual’s bone mass and compares it to that of a healthy 30-year old adult (American Bone
Health, 2020). The individuals bone mass is reported as the number of standard deviations from
the mean score of the healthy adult (T-scores).
The International Society for Clinical Densitometry (ISCD) has advised the World Health
Organization (WHO) to use the lowest T-score of either the lumbar spine, femoral neck or total
proximal femur to determine if they fall into the category of normal, osteopenia or osteoporosis
(Lewiecki, 2021). Normal bone density T-scores range from 1.0 to -1.0 (Johns Hopkins, 2021).
BMD T-scores ranging from -1.0 to -2.4 indicate low bone mass or osteopenia (Johns Hopkins,
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2021). T-scores of -2.5 or lower indicate the presence of osteoporosis and are associated with
the highest risk of fracture (Lewiecki, 2021).
Data Supporting Need for the Project
National Data
As noted previously, the national impact of altered bone mineral density is significant,
with more than 50 million women diagnosed with osteoporosis or osteopenia (USPSTF, 2018).
An estimated 1 of 2 women will develop osteoporosis in their lifetime; this incidence rate is higher
than that of myocardial infarction (NOF, 2021b). Women with decreased BMD are at risk for
developing the fragility fractures that effect more than 2 million women, primarily those age 65
years and older. As the number of older adults within the US population continues to rise, the
number of fragility fractures from osteoporosis is anticipated to increase to 3 million by 2025
(USPSTF, 2018).
Currently, the overall costs related to osteoporosis have been estimated at $19 billion
(NOF, 2021a; USPSTF, 2018), but the aging US population is anticipated to create a challenge
to Medicare, as the organization assumes the majority of costs of osteoporosis care. Thus, the
prevention of osteoporosis and the associated morbid consequences are a national initiative,
with recommended screening and implementation of interventions by healthcare providers
(Dempster, 2011).
Clinical Agency Data
The practice setting for this evidence-based practice (EBP) project will take place in a
small community setting in northern Indiana. The practice was re-modeled three years ago to
accommodate the growing population in this region and the surrounding county. This family
practice serves primarily blue collared, middle-class citizens. Providers within this practice see
patients of all ages, from newborns to older adults, and the population includes many family
generations (Family Nurse Practitioner [FNP], personal communication, June 23, 2021). The
ethnicity within the family practice is mainly Caucasian with some Hispanic population. There are
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approximately 50 patients seen by the two providers within this office per day (FNP, personal
communication, July 31, 2021). Approximately 15-20% of the patients seen per day are women
age 65 years and older who are seen for their annual wellness examination or preventative care
visit (Family Nurse Practitioner, personal communication, July 31, 2021).
Providers at this clinical site attested that obtaining a DXA scan in women age 65 years
and older occurs less often than recommended by major organizations. The team, which
includes a medical doctor (MD), family nurse practitioner (FNP), certified medical assistant
(CMA) and registered nurse (RN), inconsistently obtain the necessary information to complete an
osteoporosis risk assessment for women age 65 years and older; correspondingly, DXA scans
are not ordered. The practice NextGenÒ electronic medical record (EMR) provides an alert to
remind providers, but this tool is often overridden or ignored.
Purpose of the Evidence-Based Practice Project
Purpose Statement and PICOT Question
The purpose of this EBP project is to increase screening for osteoporosis amongst
women age 65 years and older within the primary care setting. This project will answer the
compelling clinical question: What evidence-based strategies are effective at increasing
preventative care, including osteoporosis screening? Specifically, this project will address the
following PICOT question: Among women age 65 years and older, what is the effect of mailed
patient reminders on osteoporosis screening rates via DXA scan, as compared to previous
screening rates over a 15-week time period?
EBP Project Description
This EBP project will be formally initiated on October 20, 2021, coinciding with World
Osteoporosis Day (International Osteoporosis Foundation [IOF], 2021b). Immediately prior to
World Osteoporosis Day, an educational event will be undertaken for key stakeholders within the
clinical practice; osteoporosis statistics will be reviewed, and the benefits of screening within this
population will be outlined. The intervention includes the utilization of mailed patient reminders to
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increasing screening rates of osteoporosis of women age 65 and older during their annual
wellness or regularly scheduled chronic medical visits with the provider. During these visits, all
women who meet criteria should receive verbal education by the provider on the importance of
getting a DXA scan; those accepting the screening will have an order for the DXA entered in the
EMR. Outcome will include the percentage of qualifying patients who actually complete their
osteoporosis screening (DXA completed).
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
Permission has been obtained to use the Johns Hopkins Evidence-Based Practice for
Nurses and Healthcare Professionals (JHEBP) model for this project. The JHEBP has been
noted to be straightforward and user-friendly, guiding individual or group use and enhancing
team collaboration and care coordination (Johns Hopkins, 2020); these were important
considerations for this EBP project. The newly revised JHEBP model has three major stages: (a)
Practice Question and Project Planning (steps 1-7), (b) Evidence (steps 8-12), and (c)
Translation (steps 13-20) (Dang et al., 2022). Clinical and academic feedback helped contribute
to the Johns Hopkins EBP model. This model works closely with key stakeholders. The use of
this problem-solving model implements action plans and determines the next path for front-line
healthcare teams by distinguishing best practice ultimately for the patient.
Practice Question and Project Planning
The model’s Practice Question and Project Planning stage consists of seven steps. The
following seven steps must be met prior to progressing to the second stage; recruiting an
interprofessional team (step 1), determining responsibility for the leader project (step 2),
scheduling meetings for the team members (step 3), clarifying and describing the problem (step
4), developing the practice question and refining the EBP question (step 5), determining the need
for the EBP project (step 6), and identifying key stakeholders (step 7).
Evidence
After completion of the Practice Question and Project Planning stage, the Evidence stage
begins (step 8-12). Within the Evidence stage, the initial step (step 8) involves an internal and
external search. In step 9, pieces of evidence are appraised for level and quality. Step 10
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includes a summarization of the individual pieces of evidence collected. Within step 11, a
complete synthesis of evidence is undertaken. This evidence synthesis is best completed
through group discussion with critical thinking involving subjective and objective reasoning
(Johns Hopkins Nursing, 2020). Step 12 is the development from the best evidence
recommendations for change based on evidence synthesis (Johns Hopkins Nursing, 2020). After
the team evaluates the evidence and feels the evidence can support the desired change, the
translation stage can begin. If the evidence is not found to be supportive for the practice
question, the team must go back to step eight and search for better evidence pieces.
Translation
After the Evidence stage is completed, the Translation stage can begin. Step 13 identifies
practice setting recommendations. Examination of the feasibility and balance of the risk and
benefit must be evaluated thoroughly to fit within the healthcare mission, goals, objectives and
priorities (Upstate Medical University, 2020). In step 14, an action plan is developed. Step 15
involves securing support and resources to implement an action plan. Step 16 is the
implementation of the action plan. Step 17 includes evaluation of the outcome and determination
if improvements have been made. Step 18 is the reporting of results to key stakeholders. Step 19
identifies future steps, while step 20 includes a dissemination of findings to determine if this
change can be systemwide or nationwide.
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Figure 2.1
The Johns Hopkins Nursing Evidence Based Practice Model for Nurses and Professionals Model

Note: The Johns Hopkins Nursing Evidence-Based Practice Model was used with permission
from the Johns Hopkins Hospital and Johns Hopkins University School of Nursing. (see
Appendix A for permission statement).

Application of EBP Model to EBP DNP Project
Practice Question
Consistent with the first stage of the JHEBP model, a site for the EBP project was
identified and an interprofessional team was recruited: the MD, FNP, RN, and MA. It was
determined that the doctoral student would take on the leadership role for the EBP project. The
doctoral student scheduled team meetings during which the clinical problem was clarified and
further described. The FNP and MD, providing care within the clinic setting, reported that
osteoporosis screening was not conducted as recommended by national guidelines; thus, their
rates of preventative DXA screenings warranted improvement. An EBP question was initially
developed and refined by the doctoral student to ensure that the EBP project would align with
organizational priorities. Key stakeholders were identified. These included all members of the
interprofessional team, as well as the health system’s marketing team, and informational
technology (IT) department. It was surmised that all key stakeholders provided valuable skills
that would guide the success of this EBP project.
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Evidence
Reflective of the second stage of the JHEBP model, an internal and external search for
evidence was conducted. The search was narrowed to the use of mailed patient reminders
based on fit and feasibility feedback from key stakeholders. Evidence was then leveled using
Melnyk & Fineout Overholt’ hierarchy of evidence due to the doctoral student’s previous
experience using the tool. Evidence from an EBP project report was appraised by the Melnyk &
Fineout Overholt tool. Summarizing the evidence pieces individually was conducted in
conjunction with the clinic FNP. Findings were then synthesized and the best evidence
recommendation, which involved using patient reminders to increase preventative screenings
(including DXA scans for osteoporosis) was developed.
Translation
Practice setting-specific recommendations were considered when determining the
feasibility and fit of the evidence-based intervention. An action place was developed, in
consultation with key stakeholders. Organization support for the intervention was obtained,
especially from the healthcare system’s marketing department. The intervention was scheduled
to launch in October 2021, timed to coordinate with World Osteoporosis Day.
Literature Search
Sources Examined for Relevant Evidence
An exhaustive initial search of library databases, including Joanna Briggs Institute (JBI),
Cochrane Library, CINAHL, MEDLINE with Full Text (via EBSCO), and PubMed, was conducted
to identify effective interventions for improving osteoporosis screening rates. The initial literature
search included a combination of keywords and included articles published in English within
scholarly, peer-reviewed publications within the past 10 years. The literature search included a
combination of keywords including “osteoporosis” OR “osteopenia” AND “screen” OR “improv*”
OR DXA OR “dexa scan” OR “bone density” OR “interven”. Following the initial search for best
practice interventions, strategies were reviewed with key stakeholders, who ruled out
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interventions that were impractical for the clinical setting (i.e., changes to the EMR system). A
final search for evidence was conducted in databases JBI, Cochrane Library, CINAHL, PubMed,
Medline with Full Text (via EBSCO). As the initial search returned a number of articles that
focused on the benefit of patient reminders and key stakeholders determined that this approach
aligned with their workflow, the keywords used for the final literature search were “patient
remind*” and “mailed remind*”. Articles which focused on preventative health other than
osteoporosis, were included in the supportive evidence when the patient population was the
same as the identified population for this EBP project (women age 65 years and older). Articles
were excluded from further evaluation if they did not include patient reminders as an integral part
of the intervention and those participants who had a prior diagnosis of osteoporosis. Following
the database searches, an extensive hand search of the project topic was conducted, using the
same inclusion and exclusion criteria. Citation chasing was undertaken and this resulted in one
piece of evidence.
The literature search yielded a total of 245 articles. Two hundred thirty five were deemed
irrelevant based on the subject from the title. Assessment of the abstracts were reviewed and a
total of ten articles remained. All articles were appraised by the CASP tool or the Melynk-Fineout
Overholt tool and these articles support the EBP project intervention as preventative
interventions. The two records from the internet search from experts were appraised by the
Melnyk & Fineout-Overholt Appraisal tool.
The Prisma in Figure 2.2 depicts the literature search conducted.
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Figure 2.2
EBP Project Prisma

Screening

Identification

Identification of studies via databases and registers
Records identified from*:
COCHRANE (n = 6)
CINAHL (n = 14)
PUBMED (n = 152)
MEDLINE (n = 71)
JBI=(n = 0)
Total Databases (n = 5)
Records identified by citation
chasing (n = 1)
Records of an internet
search from experts (n = 3)
Records screened
(n =7)

Records excluded**
(n = 0)

Reports sought for retrieval from
hand search (n = 3)

Reports not retrieved
(n = 0)

Reports assessed for eligibility
(n = 10)

Included

Records removed before
screening:
Records removed because of
irrelevance (n = 235)

Studies included in review
(n = 10)
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Levels of Evidence
A total of 10 pieces of evidence will be used for this DNP project: one systematic review
(SR), eight randomized controlled trials (RCTs), one cohort trial, one EBP project from a previous
DNP student, and two expert opinions from websites. The Melnyk and Fineout-Overholt
hierarchy of evidence tool (See Table 2.1) was used for rating the 10 pieces of evidence (Stillwell
et al., 2010). There are seven different levels of evidence within this hierarchy. Level 1, the
highest level of evidence, includes systematic reviews of randomized control trials (RCTs) and
evidence-based clinical practice guidelines that are based on systematic reviews of randomized
control trials. Level II includes evidence from at least one well-designed RCT, while Level III
encompasses evidence from well-designed controlled trials without randomization. Level IV
includes evidence from well-designed case control and cohort studies, while Level V
encompasses evidence from systematic reviews of descriptive and qualitative studies. Level VI
includes evidence from a single descriptive, or quality study, while Level VII, the lowest level of
evidence, is comprised of the opinions of authorities and/or reports (Stillwell et al., 2010).
The analysis and appraisal for 10 pieces of evidence was conducted using the CASP
tools and the Melnyk & Fineout-Overholt Rapid Critical Appraisal. Using the CASP tools, all SRs
and RCTs were found to be of moderate or high quality. Using Melnyk & Fineout-Overholt Rapid
Critical Appraisal, the EBP Project report and two expert opinions, which was determined to be of
high quality. Table 2.3 below describes the summary of evidence pieces.
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Table 2.3
Summary of Evidence
_____________________________________________________________________________
Author/Year
Database
Level of Evidence/Type
Quality/Tool
_____________________________________________________________________________
Jacobson et al., 2018

Cochrane Library I/Systemic Review

High/CASP

Chan et al., 2018

CINAHL

II/RCT

High/CASP

Coronado et al., 2018

CINAHL

II/RCT

High/CASP

Hirko et al., 2020

CINAHL

II/RCT

Moderate/CASP

Levy et al., 2013

CINAHL

II/RCT

Moderate/CASP

Lipscomb et al., 2020

PUBMED

II/RCT

Moderate/CASP

Warriner et al., 2012

MEDLINE

II/RCT

High/CASP

Black, 2014

Web Search

VI/EBP Project expert

High/Melnyk &
Fineout-Overholt

CDC, 2021

Web Search

VII/Expert Opinion

High/Melnyk &
Fineout-Overholt

Health Partners, 2021 Web Search

VII/Expert Opinion

High/Melnyk &
Fineout-Overholt
_____________________________________________________________________________
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Analysis and Appraisal of Relevant Evidence
The quality of the pieces of evidence were appraised using the CASP tools and for
appraising systematic reviews and randomized controlled trials. The 10 question CASP tool
examines the trustworthiness and relevance of the selected pieces of evidence (Critical
Appraisal, 2021). Ten questions will be answered by the evaluator as either: “yes”, “no”, or “can’t
tell”. The Melynk & Fineout-Overholt rapid critical appraisal tools were used to evaluate the
quality of the EBP project and the two expert opinions on the internet. Similar to the CASP,
Melnyk & Fineout-Overholt rapid critical appraisal utilizes 22 questions that the evaluator can
answer “yes”, “no”, or “unknown” (Stillwell et al., 2010).
Construction of Evidence-based practice
Synthesis of Critically Appraised Literature
A critical review of appraised literature revealed a number of themes related to best
practice. Specifically, the literature was reviewed in light of frequency and/or timing of the
reminders, length of time to outcome measurement, and method of outcome measurement. The
CDC’s recommendation based on research with these foci, does not include these measures
within the recommendation statement.
Patient reminders
Research authors of 8 pieces of evidence reported that mailed patient reminders, which
included letters from the provider(s), increased preventative care screening (Black, 2014; CDC,
2021; Coronado et al., 2018, Health Partners, 2021; Jacobson et al., 2018; Levy et al., 2013;
Lipscomb et al., 2020; & Warriner et al., 2012). Although a number of consistencies were noted
within this portion of the body of evidence, a few differences were apparent: i.e., timing of the
mailings, length of follow up, and statistical analyses used to determine outcomes.
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Within some the pieces of literature, the authors described the period of time when
mailed reminders were sent. Based on the target screening, the overall time frame for when the
mailings were sent was scattered throughout a 12-month time period for both colorectal cancer
screenings (Coronado et al., 2018) and breast cancer screenings (Lipscomb et al., 2020). In
addition, the time frame for when the mailings were distributed through mailings for osteoporosis
screening reminders and immunization reminders was over a 12-month time period (Jacobson et
al., & Warriner et al., 2012). The reminder mailings were sent once during a 12-month time
frame.
Follow up on the mailings varied from the pieces of evidence. Follow up on the mailed
reminders were conducted at six months if the DXA was not scheduled (Warriner et al., 2012). At
the 15-month time period follow up occurred when colorectal screening results were reviewed
(Levy et al., 2013). At the 3- and 12-month time period following the mailed reminders, the
mammogram screening rates were evaluated (Lipscomb et al., 2020). Within Black (2014) EBP
project, the follow up on DXA screens was 12 weeks. Health Partners (2021) followed patients
for a period of two years. Other researchers did not report the number of times that the mailed
reminders were sent or needed to be sent (CDC, 2021; Coronado et al., 2018 & Jacobson et al.,
2018). Coronado et al., included a stepwise mailing, with an introductory followed by the mailed
test, and a reminder letter. There was not listing of the time period of the sequential mailings.
Coronado followed patients to determine who completed the FIT within 12 months; so, there was
a 12 month follow up period. Warriner only had one mailing, with the ability to self-schedule and
this study had a follow up time period of 6 months. Chan et al (2018) had follow ups between six
and 24 months. Levy et al (2013) had follow ups at the six-month mark. Health Partners (2021).
In reporting outcomes, data analyses from the supportive evidence most commonly
included percentage change and less frequently reported risk reduction or odds ratio. Details of
these outcome measures are outlined in the paragraphs below.
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The effectiveness of mailed reminders for improving preventive care was also supported
by researchers who used analyses other than percentage point increases. Coronado et al., found
that their mailed reminder resulted in a 3.4-percentage point increase in screening rates (13.9%
for the intervention group as compared to 10.4% for the control group; a 24.3% difference). Chan
et al (2018) reported a greater than 10-percentage point difference in screening rate (34.4% for
the intervention group as compared to 24% for the control group. Libscomb (2020) reported a
59.5% screening rate for breast cancer survivors. Hirko (2020) reports a 7.6% increase in
screening rates of colorectal cancer. Levy (2013) noted an increase in screening rates with
patient reminders by 38.7%. Health Partners (2021), a group of clinics in Minnesota, reported
positive outcomes for the use of mailed reminders for a number of preventive care measures: a
modest 0.7 percentage point increase for breast cancer screenings; a greater than 17percentage point increase for immunizations. Black (2014) reports a 14-percentage point
increase in the osteoporosis screening rates.
The effectiveness of mailed reminders for improving preventative care was also
supported by researchers in four studies who used analyses other than percentage point
increases. Chan et al., (2017) reported in increase (RR =1.41; 95% Cl [1.30-1.54]). Evaluation of
effectiveness of mailed reminders versus recall in those who were immunized revealed a
RR=1.29, 95% Cl [1.21-1.31] (Jacobson et al., 2018). Within the Levy et al (2013) study,
preventive colorectal screening by mailed patient reminder was associated with an increased
rate of screening (OR = 6.0) while adding a telephone call reminder to the mailed reminder
resulted in only a modest increase in the odds ratio (OR = 6.2). Warriner et al. (2012) revealed a
high probability that patient mailed reminders increased screening rates OR = 3.8; 95%Cl [1.74.8].
Patient Reminder with Motivational Message
Within the literature evaluated for this EBP project, two groups of researchers included
motivational messaging within the provider-signed reminder letter that noted that the preventative
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care was overdue (Chan et al., 2018; Hirko et al., 2020). Within both of these studies, outcomes
were measured by percentage point increases differences: the slightly greater than 10percentage point increase within Chan et al., (2018) and 7.6 percentage point increase within
Hirko et al., (2020). Of particular importance in the planning of this EBP project, is the finding
(reflected in Appendix C) that the inclusion of motivational messaging did not improve preventive
care rates.
Mailed Brochure and Self-Scheduling Instructions
The effect of including self-scheduling instructions with patient reminders (a mailed
brochure) was examined within one study that was included in the evidence base for this EBP
project (Warriner et al., 2012). Of note is that Warriner et al’s (2012) research was specific to
osteoporosis screening; and their DXA completion rates were more than 12-percentage points
greater in those who received the self-scheduling instructions (17.3%) than the usual care group
which is those who had standard reminder to self-schedule. These outcomes approximate those
of researchers that did not include motivational messaging with their patient reminder.
Mailed Patient Reminder and Provider Chart Reminder
Within one study that was included in the evidence base for this project, the researchers
implemented a combination of mailed patient reminders plus a form that encouraged the provider
to note the patient’s elevated risk status within the medical record and note the engagement of
appropriate screening (Lipcomb et al., 2020). This flagging system did remind the provider of the
risk based on history in two groups: high and low intensity groups with a 60% of first degree
relatives increase in preventative mammograms and 72% increase in breast cancer survivors as
compared to the low intensity (brochure only) group (Lipscomb et al., 2020). Follow up of this
study was 12 months.
Recommendations from Major Healthcare Organizations
National organizations (i.e., CDC, 2021; Health Partners, 2021) support and/or
recommend the use of patient reminders to enhance preventive care. These broad-based
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recommendations typically do not include suggestions on how to measure changes in outcomes,
how frequently to issue the reminders, or how long after intervening to measure the change in
outcomes. Nonetheless, their recommendations, which are grounded in research, provide
support for the use of mailed patient reminders.
Recommendation for Best Practice
Based on the synthesis of evidence, and an evaluation of the feasibility of these
interventions at the designated project site, it was determined that the most appropriate
intervention is a mailed patient reminder, delivered once with a signature from the provider with
motivational messaging. The patient mailed reminders of the recommended screening test of a
DXA screen will be sent once on October 20, 2021 with the recommendation of getting this
screening test. Follow up measurement will weekly to measure if the participant obtains this
screening tool.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
Women age 65 years and older are known to be at risk for osteoporosis. Undetected
osteoporosis is a silent disease. Early screening can detect this disease and prevent fragility
fractures. This DNP project aimed to increase rates of osteoporosis screening in a primary care
setting through the use of mailed patient reminders.
Participants and Setting
This EBP project was taken place in a family practice setting in a small city in northern
Indiana. Within this practice, patients are cared for by an FNP and MD. The FNP is female and
has been in practice for over 4 years. The MD is male, and he has been in practice for over 24
years. The participants in this EBP project, patients of the FNP and MD, consist of women age
65 who do not have a record of previous DXA scan within their EMR. Participants who have
previously been screened or have a diagnosis of osteoporosis or osteopenia via other testing will
be excluded. These participants who have a diagnosis of osteoporosis or osteopenia diagnosed
by DXA or other testing will be excluded. The time frame for collecting data from the participants
will be from October 20, 2021-February 2, 2022.
Pre-Intervention Group Characteristics
The practice initially identified 212 women who were age 65 and older. Of these, 14
women who were excluded from this EBP project because they were no longer active in the
practice or were in hospice care. Of these 198 active older adult women, 77 active patients
(38.9%) did not have record of a DXA within the EMR. Of those 77 patients, nearly three-fourths
(74% were patients of the physician (n = 57) and the remaining 20 patients were identified as
patients of the FNP (26%). Of the 77 women without a record of a DXA scan within their EMR,
97.4% were non-smokers (75 participants) and 2.6% were smokers (2 participants); 83.1% had
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Medicare (64 participants), 14.3% were private insurances holders (11 participants), and 2.6%
were Medicaid (2 participants). The age group category of 65-74 included 44 females (57.1%).
The age group category of 75-84 included 23 females (30%). The age group category of 85
years and older were 10 females (12.9%).
Of the women who have had a DXA screens per documentation on their EMR (n = 121);
17 were patients from the NP (14%) and 104 were patients of the MD (86%).
Intervention
During the planning phase of the project, key stakeholders provided significant insight
and guidance into the development of the intervention. The DNP student worked with the
marketing department within the health system to develop the mailed patient reminder. Based on
their knowledge of the patient population, key stakeholders determined that the appropriate
reading level for them would be that of a 12-year-old. The physician and NP were provided drafts
of the proposed letter at least three times, and revisions were made based on their feedback; the
final edits of the mailed reminder were approved by both the physician and the NP and sent to
marketing for printing.
The physician and NP were also integral in determining a launch day for the intervention.
The DNP student recommended initiating the intervention within the month of October, on a day
that correlated with World Osteoporosis Day. All key stakeholders were in agreement that the
October launch date was feasible for the practice. The final determination was that the
intervention would launch on October 14, 2021. On that date, the marketing department sent out
the mailed patient reminder to all women age 65 and older within the practice who had been
identified, through EMR review, as not having a DXA scan within their medical record. The
reminder letter (see Appendix F) addressed the benefits of screening for osteoporosis via DXA
scan and provided the office phone number for those wanting to schedule the DXA scan or
electing to discuss further with the provider at an office visit.

21
To prepare for the launch of the intervention, a meeting was scheduled via zoom on
Tuesday, October 5, 2021 for the NP, MD and all support staff were provided of education that
included a review of a PowerPoint (see Appendix G) which included statistics addressing the
benefit of DXA screening. Front office staff who answer the telephones were given a clipboard of
the patients who were mailed the patient reminder in case the patient called in asking about this
reminder letter.
Beginning on October 14th, the following changes would be implemented within the
practice. All patients receiving the mailed reminder would contact the office via telephone to (a)
request that the DXA would be scheduled or (b) schedule an appointment with the provider to
further discuss the need for screening. For those who elected to proceed with screening, the
front office staff will send a “task” via the EMR to the RN, notifying her of the patient’s request to
schedule the DXA scan. The front office would also add a check mark to the patient’s name
where this was not visible to other patients. The clipboard was used to tract the patients who
called in to schedule their DXA after receiving the mailed reminder. was mailed out on October
14, 2021 at 0700 at this practice setting by verbal education. Ultimately, the task within the
patient’s EMR will track whether the patient called in to inquire about this reminder letter or the
EMR will reveal if this was discussed at the patient’s office visit. For the patient electing to
schedule an appointment to discuss further with the provider, the physician or NP will educate
the patient the benefits and limited risks of screening. Then, the providers will answer any
questions and, if the patient is willing, enter the DXA order into the EMR system.
Every week this DNP student hand searched the 77 patients to see if they called in and a
telephone encounter was formed. If the patient was seen at an office visit, the encounter will be
reviewed by this student and an ongoing excel spreadsheet will be reviewed on the patients sent
the reminder.
Comparison
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The population of women age 65 years and older will be comparison group from the
literature evidence pieces. The literature pieces was tested against the median value of a result
from the literature, 11.65% (3.5%, 7.6%, 10.4%, 11.2%, 12.1%, 14.0%, 38.7% and 59.5%)
(Black, 2014; Chan et al., 2018; Coronado et al., 2018; Hirko et al., 2020; Jacobson et al., 2018,
Levy et al., 2013; Lipscomb et al., 2020; Warriner et al., 2012).
Outcomes
The primary outcome of this study was the change in percentage of women age 65 years
and older who had undergone a DXA screening. This was consistent with the supportive
evidence with review of the literature from Chan et al., 2018, Coronado et al., 2018; Hirko et al.,
2020, Levy et al., 2013; Warriner et at., 2012. A secondary outcome was the percentage of those
screened who are diagnosed with osteopenia or osteoporosis, as the providers within the
practice requested this data; reports of this outcome will be provided in descriptive format only.
Time
The timeline for implementation of this project is outlined in table 3.1.
Table 3.1: PET Process Guide

EBP Work Plan
Initial EBP question: Among women age 65 years and older, what is the effect of mailed
patient reminders on osteoporosis screening rates via DXA scan, as compared to previous
screening rates over a 15-week time period?

EBP team leader(s): Kacy Davis, FNP
EBP team members: Dr. Julie Koch, Dr. Berger, Mackenzie Shireman, DNP, MA, RN
Goal completion date: April 2022
Steps
Practice
Question &
Project
Planning

1. Recruit
interprofessional
team

1
5/21

2.
Determine
responsibility for
project leadership

5/21

3.
Schedule
team meetings

5/21

2

3

4

Month
5
6

7

8

9
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4.
Clarify &
describe the problem
(App. B)

Evidence

6/21

5.

Develop &
refine the EBP
question (App. B)

5/21

6.
Determine
the need for an EBP
project

5/21

7.
Identify
stakeholders (App. C)
8.
Conduct
internal & external
search for evidence

5/21
5/21

Appraise the
level & quality of
each piece of evidence
(Apps. E/F)

6/21

9.

6/21

10.

6/21

Summarize
the individual
evidence (App. G)

11.
Synthesize
findings (App. H)

7/21

12.

Translation

6/21

Develop best
evidence
recommendations
(App. H)

7/21

13.
Identify
practice setting–
specific
recommendations
(App. I)

7/21

14.

Create action
plan (App. I)

8/21

15.
Secure
support & resources to
implement action plan

8/21

16.

Implement
action plan

8/21
9/21

10/21

11/21

12/21

17.
If change is
implemented, evaluate
outcomes to
determine if
improvements have
been made
18.
Report
results to stakeholders
(App. C)

2/22

19.

3/22

Identify next
steps

1/22

2/22

1/22
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20.
Disseminate
findings (App. J)

4/22

3/22

Implementation of this EBP project began on Wednesday, October 20, 2021, correlating
with World Osteoporosis Day. The Johns Hopkins Nursing Evidence-Based Practice Model uses
evidence to translate into best practice within practice improvements such as this implementation
of this intervention.
Protection of Human Subjects
This DNP student completed CITI training (see Appendix D) on March 23, 2021. This
EBP project was given approval by the clinical site office health system’s IRB board on July 30,
2021; following the DNP student’s review and acknowledgement of compliance with the system’s
HIPAA policy. The IRB board at Valparaiso University determined that this EBP project did not
meet the Federal definition of research on August 3, 2021; no further oversight would be
provided. As the intervention for this project was an evidence-based change in practice, informed
consent was not needed from patients within the practice, but the physician and NP provided
their support for the practice change verbally. Chart audits were conducted on site in an office
within the practice that was only available to this student during the time of the audits and data
were de-identified prior to analyses. Outcome data will be reported in only in aggregate form; no
identifiable information regarding any patient will be released or disclosed.
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CHAPTER 4
FINDINGS
The purpose of this EBP project was to increase DXA screening rates in women at their
local primary care facility. The primary outcome of increased screening rates was measured by
the females getting the DXA screen within this 15-week time period.
Participants
The pre-intervention group consisted of 77 female participants who had not had a DXA
screen. After further review of this group, two women were in hospice and three were deceased
leaving a final analyzable cohort of 72 women. Out of these 72 women, 81% were patients of the
physicians (n=58) and the remaining 14 patients were identified as patients of the FNP (19%). Of
the 72 women who were mailed patient reminders, 71 were non-smokers (99%) and 1 was a
smoker (1%); 97% had Medicare (n=70), 0% were private insurance holders, and 3% Medicaid
insurance (n=2). Sixty-three percent (n=45) of females were age 65-74. Twenty-three females
(32%) were age 75-84. The remaining 6% (n=4) of patients were age 85 and older.
Mailed reminder letters were sent to all 72 women. As a result, six women (8.3%; 95% CI:
3.12%- 17.30%) got the DXA screen during the 15-week time period. Of those six women who
were mailed reminders and who underwent the DXA screen, 83.3 % were non-smokers (n=5)
and 16.7% were smokers (n=1); and all had Medicare insurance. There were not any self-paying
or Medicaid participants. Two-thirds (67%, n=4) were age 65-74 and one-third of the patients
(n=2) were age 75-84. There were no patients 85 or older. (See Table 4.1)
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Table 4.1
Demographic Characteristics for those who had DXA screen
____________________________________________________________________________
Smoking history
Non-smokers

83.3% (5 participants)

Smokers

16.7% (1 participant)

Insurance
Medicare

100% (6 participants)

Self-pay

0% (0 participants)

Medicaid

0% (0 participants)

65-74

66.7% (4 participants)

75-84

33.3% (2 participants)

85+

0% (0 participants)

Age

_____________________________________________________________________________
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The result of 8.3% was tested against the median value of a result from the literature,
11.65% (3.5%, 7.6%, 10.4%, 11.2%, 12.1%, 14.0%, 38.7% and 59.5%) (Black, 2014; Chan et
al., 2018; Coronado et al., 2018; Hirko et al., 2020; Jacobson et al., 2018, Levy et al., 2013;
Lipscomb et al., 2020; Warriner et al., 2012). The proportion of women who were screened
because of this reminder letter was no different than results from the literature (binomial test,

p=.465). This result is not statistically significant. The results from this binomial test indicate that
they were not clinically, significantly different from the literature and this is optimistic for this
intervention.
Secondary outcomes from the reminder letter identified three women with osteopenia
(50%), two women with osteoporosis (33.3%) and one woman had a normal DXA scan (16.7%).
With these six female participants who participated with this intervention, this represented the
female population within this practice setting who obtained the DXA screen. Both providers at
this office encouraged DXA screening.
Changes in Outcomes
This EBP project addressed the following PICOT question: Among women age 65 years
and older, what is the effect of mailed patient reminders on osteoporosis screening rates via DXA
scan, as compared to previous screening rates from mailed reminder letters evidence of
literature over a 15-week time period? The primary outcome measured for this project was
participant completion of DXA screen.
Statistical Testing and Significance
For data entry, SPSS was utilized. For statistical analysis, this student had a well-known
statistician, Gregory Gilbert who analyzed this data. A one-sample binomial test was used for this
data analysis to determine if the observed results differed from results from the literature.
Reliable testing from a collection of disparate environments can often be an occurring problem
(Myhre et al., 2018). Comparing estimation results from two different proportions gives clear
results via the binomial test for statistical analysis.
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Findings
Primary Outcome
There was an 8.3% success rate of the DXA screening as a result from the patient mailed
reminder letter to those 72 women who received this in the mail. There was a total of six
participants who underwent the DXA screen. The 95% confidence interval of the specified
probability was 3.12% and 17.30%. The median value of the results from the evidence of
literature was 11.65% therefore the proportion of those who did get the DXA screen because of
this reminder letter was no different than results from the literature (binomial test, p=.465).
Secondary Outcome
There were three female participants who had a result of osteopenia from the DXA scan
(50%). There were two female participants who had a result of osteoporosis from the DXA scan
(33%). There was one female participant who had a normal DXA scan (17%). (See Figure 5.1)
Figure 4.1
Secondary data

Females who underwent DXA
Normal DXA
17%

Osteopenia
50%
Osteoporosis
33%

Osteopenia

Osteoporosis

Normal DXA
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CHAPTER 5
DISCUSSION
The EBP project served the purpose of addressing the effect of patient mailed reminder
letters on osteoporosis screening rates via DXA scan on previous screening rates in those who
have not had a DXA screen. Upon learning that 72 women patients did not undergo a DXA
screen at a small PCP office in northern Indiana, this EBP identified six who did undergo the
DXA as a direct result of the patient mailed reminder letter. National clinical guidelines
recommend women age 65 and older to receive a DXA to identify if they are at risk for
osteoporosis. The interprofessional team of two providers, one nurse, and this DNP student was
formed. An extensive review of literature was performed in detail. As a direct result of a synthesis
of literature, best practice was identified. Screening based on patient mailed reminders were
identified in the literature and patient mailed reminder letters were the best practice. This EBP
project goal was to increase osteoporosis screening rates in the primary care setting.
Explanation of Findings
Prior to the implementation process of this EBP project, this student worked closely with
the IT department for the practice site to identify those women age 65 and older who had not had
a DXA screen within the EMR system. The data collected revealed 77 women who had not had a
DXA screen from a total of 212 females age 65 and older in this local primary care practice. After
further analysis, the total women who did not undergo a DXA were further reviewed and two of
the women were in hospice and three passed away during the 15-week data collection period.
The final total of the women who did not undergo a DXA screen was narrowed down to 72
women. The PICOT question for this EBP project concentrated on women ages 65 and older and
the effect of patient mailed reminders on osteoporosis screening rates via DXA scan as
compared to previous screening rates over a 15-week time period. The findings following the
implementation of this EBP project are discussed below.
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The primary outcome for this EBP was designed to measure the total number of women
who had a DXA screen as a direct result from the mailed patient reminder letter. A total of six
women completed the DXA screen out of 72 female participants. The percentage of participants
who completed the DXA screen was 8.3%. The percentage rate of those who did have the DXA
was tested against the median value of the pieces of literature who underwent a screening as a
result of a mailed reminder letter. The eight pieces of evidence were analyzed, and the median
value of the literature was 11.65% who underwent screening as a result of a patient mailed
reminder letter. Data analysis with this student’s statistician used the binomial test to compare if
this was statistically significant. The six women who underwent the DXA screen within the 15week time period within the total cohort of 72 women because of the reminder letter was no
different than the results from the literature (binomial test, p=.465). Statistically, the result was
not significant. Clinically, the results were not clinically significantly different from the literature
therefore this implementation of the mailed reminder letter is hopeful for future screening
interventions. Phone calls were made weekly to those female participants inquiring if they would
undergo DXA screening and, if they did complete this screen, the final result of the DXA.
Secondary outcomes were identified results from the DXA scan when the female
participants completed the DXA screen. A total of three women were diagnosed with osteopenia,
two women were diagnosed with osteoporosis, and one had a normal DXA scan. Results from
the DXA screen were reviewed with their provider via the telephone, telehealth, or in the office.
Strengths and Limitations of the DNP Project
The Johns Hopkins Evidence-based Practice for Nurses and Healthcare Professionals
model was used for this EBP project. This model guided this student in a straightforward and
user-friendly manner for the success of this project. The practice question and project planning
(steps 1-7) aided in the organization of this EBP project. The mailed reminder letter served as an
effective intervention from the evidence collected from literature (steps 8-12). Steps 13-20 served
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to translate findings and to disseminate accordingly. Key stakeholders were closely intertwined
within the production of this EBP project.
Strengths
Several strengths were evident within this EBP. A thorough review of literature was
conducted and countless databases were searched. All searches were improved with an
excellent librarian who helped this student tremendously at Valparaiso University. Several
databases were reviewed to help reveal excellent pieces of evidence. With the help of this
student’s advisor, 10 pieces of evidence were finalized from the literature search.
Support staff from the IT department from the health system where this EBP project took
place were extremely helpful. Data was plucked several times and all IT personal were
accommodating when inquiring about project data. Support staff from the marketing department
from this health system were beneficial when designing the reminder letter for the participants. A
marketing specialist helped this student design the reminder letter and graciously accepted
responsibility of mailing the reminder letters for the 72 females. This was a benefit from this
student being employed by this health system and implementation of the EBP project within this
system.
This EBP project was successful due to the key stakeholders’ present while this project
took place. Without this student’s advisor and clinical advisor, this project would not have been
as successful. This student’s clinical advisor showed this student where to find any previous
screening questions within the EMR system and where they may be scanned within the patient’s
chart. This student’s clinical advisor had been there every step of the way when any questions
did arise during this process. This student’s academia advisor the first semester (Dr Julie Koch)
was helpful when deciding what was the best pieces of evidence from the literature and critiquing
my EBP project. Without the support from Dr. Koch and the constant encouragement through
text message and phone calls, this EBP project would not be as successful. This student’s
academia advisor the second semester (Dr. Mackenzie Shireman) was extremely encouraging
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when helping this student prepare for the final stretch of this EBP project. All the concerns and
many questions this student had were discussed instantly via text messaging or phone call. Dr.
Shireman has been inspiring!
Calling the female participants who did not have any documentation on their EMR after
mailing the mailed reminder allowed this student to discuss the reminder letter and many of the
females enjoyed the personalized letter. The cohort of female individuals who answered the
phone were appreciative of the phone call and expressed reasoning if they did not choose to
undergo the DXA screening.
Limitations
Despite the strengths of this EBP project, several limitations were encountered. The most
significant limitation of this EBP project was that the female participants declined to undergo the
DXA screen. Several phone calls did reveal the failure of getting a DXA screen in the past
despite having their PCP encourage them at several previous medical appointments. Several
females within this cohort did not answer their phone calls when this student called to inquire.
Voicemail was not left on their messaging system due to the influx of phone calls this office may
get as a direct result and this was limiting.
This EBP project took place during the fall of the second year of the COVID-19 pandemic.
Several restrictions were still in place from the pandemic and this implementation process
occurred during the late fall and winter months. With Indiana weather, this could have been a
factor to the limited amount of DXA screens performed during this 15-week time period.
Staffing at the imaging center that this office refers all DXA screens was limited. This
could have factored into the low levels of rates that did participant in the DXA screening. The
average wait time for scheduling for a DXA screen is 2-3 weeks after the referral is placed within
this health system.
Sustainability
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Actions taken to sustain the project at this clinical site were to continue encouragement
of the DXA screening to those women age 65 and older who did not already obtain a DXA. The
clinical site has a limited staffing situation at this office setting and is considering adopting the
patient mailed reminder letter. The EMR system is going to be changing within the next year into
a more universal documentation system that correlates with the hospital EMR system. The
medical doctor would like to continue this patient mailed reminder for many various screening
tools that the patient needs but time is of the essence and this is limited to staffing. If this student
had the opportunity to redo this project, recommendation would be to have a larger collection
time of up to a year and to incorporate the spring and summer months since females might be
more apt to going out on warmer days.
Relevance for EBP Model
The Johns Hopkins Evidence-based Practice for Nurses and Healthcare Professionals
model to guide this EBP project was extremely useful to this student. The first step when using
this model was identifying the question that can be answered with research from evidence.
Evidence was gathered from many comprehensive literature searches within the Valparaiso
University databases on the library website. This student’s clinical question was focused using
the PICO formula. This model is organized so that the best clinical problem can be focused into
the best answerable question. The second step was to gather the best evidence to answer the
PICO question. This student had many keywords and phrases at the beginning when trying to
figure out the best pieces of evidence within the databases. Least helpful searching tips were
that one can do a hand search, and this was recommended towards the end of one of our
educational sessions with the advisor. Lastly, the third step was translating evidence into
practice. This student would recommend placing a mini step between steps two and three. The
mini step would organize all the evidence pieces and thoroughly analyze the pieces before
translating into the practice setting. This mini step is missed but this step is a huge time
commitment when reading all the evidence on the clinical questions. Overall, this student feels
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this EBP model is straightforward, yet concise. The final third step brings together all the
evidence into the practice setting.
Recommendations for the Future
Research
The results of this EBP project were affected by the time period this project was taking
place -the midst of a pandemic. Further research is necessary to study the effects of patient
mailed reminders from web-based interventions or physical based interventions, such as a
pamphlet on improving rates of DXA screenings. Various interventions can be researched and
be evaluated for usefulness in clinical practice. Several pieces of evidence discussed option of
FRAX risk score and how this can be intertwined within the EMR system. This was not feasible
for this EBP project, but further research could focus on the use of the FRAX scoring system
within future EMR systems.
Education
Commitment to lifelong learning stems from the APRN’s desire to be informed about best
practices and the interventions or resources available for use. Education is necessary to inform
female participants why completion of a DXA screen is important. Continued education about the
effects of not performing this screening for osteoporosis should be examined at a greater depth.
While it makes sense to screen women age 65 and older for osteoporosis, the risk of not having
this screening performed can have devastating effects for their future.
Conclusion
The incidence rate of women who will develop osteoporosis in their lifetime is 1 in 2
women and this is only expected to increase (NOF, 2021b). It is important that primary care
providers, including APRNs, continue to screen patients according to the national clinical
guidelines. The USPSTF recommends all women age 65 years and older undergo a DXA test to
screen for osteoporosis (USPSTF, 2018). This recommendation is a grade B recommendation
and this screening tool is accurate for detecting osteoporosis and for forecasting fracture risk.
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This EBP project sought to answer the following PICOT question: Among women age 65
years and older, what is the effect of mailed patient reminders on osteoporosis screening rates
via DXA scan, as compared to previous screening rates from mailed reminder letters evidence of
literature over a 15-week time period? There was a nonsignificant increase in osteoporosis and
osteopenia screening uptake over the 15-week time period. The proportion of women who were
screened because of this reminder letter was no different than results from the literature
(binomial test, p=.465). This result from this EBP project was not statistically significant, but the
results from this binomial test indicate that they were not clinically, significantly different from the
literature. A larger sample size and a longer time frame without presence of a pandemic would
explore significance of this mailed reminder letter intervention.
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APPENDIX A
The Johns Hopkins Nursing Evidence-Based Practice Model Permission
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Appendix B: Literature Search
Database/Resource
Searched

Keywords/Phrases
Used

Joanna Briggs
Institute (JBI)

“patient remind*” AND “mailed remind*”

2011-current

0

Number of Pieces
of Evidence
Selected for Use
In Paper
0

Cochrane Library

“patient remind*” AND “mailed remind*”

January 2011-current

7

0

CINAHL

“patient remind*” AND “mailed remind*”

January 2011-current
English Language
Scholarly (peer reviewed)
journal

15

4

PUBMED

“patient remind*” AND “mailed remind*”

Within past 10 years,
guidelines

152

1

Medline with full
text

“patient remind*” AND “mailed remind*”

English language, Past 10
years, scholarly (peer
reviewed)

71

1

List the Title of the Article/Original Piece of
Evidence that contained
the “Citations Chased”

Limiters
Used

Number of
Results
from Search

Number of
Pieces
Searched

Number of New
Pieces of “Chased”

2
Evidence
Selected for Use
Pieces of Evidence
selected that were
“Citation Chased”
from systematic
reviews, evidence
summaries,
guidelines, etc.

A randomized intervention of Reminder letter
for Human Papillomavirus vaccine series
completion

N/A

1 (from
Cochrane
Library)

1

N/A
N/A
N/A
N/A

Pieces of Evidence
selected that were
“Hand Searched”
from the table of
contents of specific
journals

List the Title of each of the Journal(s)
that were “Hand Searched”

List the Years/Time Frame
that was Searched

Number of
Pieces
Evaluated

Journal of Nurse Practitioners

2011-current

2

Number of New
Pieces from “Hand
Searching”
Selected for Use
0

Valpo Scholar- The effect of patient reminders
on osteoporosis screenings 2014
Google Scholar-University of MississippiIncreasing Osteoporosis Screening rates
CDC: Client (patient) reminder planning guide
Health Partners

2011-current

1

1

2011-current

1

0

2011-current
2011-current

1
1

0
1

Total Number
of pieces of
Evidence

10
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Appendix C: Evidence Table
Lead Author/
Year/Quality

Purpose/
Design/Sample

Interventions

Measurement/
Outcomes

Results/
Findings

Strengths/
Limitations

Level I Evidence
Jacobson et
al., 2018.
CASP tool:
high quality

To evaluate
effectiveness of
various types of
reminder and
recall
interventions to
improve
(preventative
care)
immunization
rates.
SR of 27 of
RCTs
N=81,100
participants
including women
age 65 years
and older

Mailed letter
reminders versus
recall

320 per 1000 Control
group of mail reminder
who had receipt of
preventive care
(immunizations)
412 per 1000 with
intervention of mailed
reminder who had receipt
of preventive care
(immunizations) with an
unknown period of time

RR = 1.29, 95% Cl
[1.21-1.31]
Preventive care
(immunization rates)
increased with mailed
reminders
32% (control group)
compared to 41.2%
of the intervention
group

Strength:
Moderate
evidence
grade per
study
Limitations:
Did not
focus
specifically
on DXA

4

Level II Evidence
Hirko et al.
2020.
CASP tool.
Moderate
quality

To determine if
motivational
message
reminder
increased
preventive care
(colorectal
cancer [CRC])
screening rates).
RCT
N = 7,812 adults
aged 50-75

Mailed
motivational
message screen
reminder or
standard invite
letter stating
patient was due
for preventive
screening for a
one-time mailing

Participation of
preventive care (CRC),
date of completion, follow
up testing.
Outcomes: Preventive
care (CRC screening)
participation within 6
months after the mailed
reminder letter.

Preventive care
(CRC) participation
increased with the
intervention.
Motivational
message screen
reminder) by 30.1%
versus the control
standard group at
22.5%. Intervention
group had 49%
higher odds of
preventive care
(screening) than
control (OR = 1.49,
95% Cl = 1.34,
1.65).

Strengths:
Lost cost
intervention.
Limits:
adults ages
50-75 and
those above
75 years of
age were
not
screened,
within 1
rural
community
health
system; did
not focus
specifically
on DXA

5

Levy et al.,
2013
CASP tool:
moderate
quality

Main objective
was to complete
preventive care
(colorectal
cancer)
RCT
N = 743 patients
at 16 rural family
physician offices
for women ages
65 and older

Patients randomly
placed in 1 of 4
groups: (1) usual
care; (2) physician
chart reminder; (3)
mailed reminder
with FIT reminder
magnet (4) mailed
reminder with
telephone call to
provide education/
explanation

Main outcome:
Completion of preventive
care (CRC screening).
Secondary outcome:
FOBT, FIT, barium
enema, flex sig.

Preventive care
(CRC screening)
completed: (1) usual
care (17.8%) (2)
chart reminder
20.5% (3) mailed
reminder group (4)
mailed reminder
plus telephone
57.2%

Strengths:
Setting of
PCP office
who
randomized
patients
who needed
to be
screened.
Limits: Rural
Iowa with
limited
geographic
region.

6
Coronado et
al., 2018.
CASP tool:
high quality

To determine
effectiveness of
mailed reminder
with materials to
improve
preventive care
(completion of
colorectal
screening
increase FIT
rates).
RCT.
N = 41,193
eligible
participants that
were overdue for
their colorectal
cancer
screening

Generation of
mailed reminders
with patient
materials for
preventive care
(CRC screen)
versus Standard
process of
ordering screens
during routine
clinical encounter

Intervention group:
N=21,134) Mailed
reminder letter, intro
letter and FIT kit packet;
Control group is usual
care (N = 20,059).

Intervention group
had higher preventive
rate of FIT test (from
13.9% to control
group 10.4%) 95%
CI, 0.1%-6.8%)
Intervention group
improved preventive
care (CRC screen)
rates with mailed
reminder.

Strengths:
increase in
preventive
care (CRC
screening).
Limitations:
Some of
the
preventive
care (CRC
samples
were
unable to
be
processed
due to
missing
collection
dates.)

7
Chan et al.,
2017.
CASP tool:
high quality

To evaluate if a
family PCP
signed reminder
letter to women
overdue for
preventive care
(screening
mammograms)
prompted
rescreening in 6month period.
Randomized
double-blind
trial.
N = 822 PCP.
N = 5638 women
participants

Signed Reminder
letters by PCP to
women overdue for
preventive care
(mammogram)

Those who received
preventive care
(screening
mammogram).

Those is the intervention
group were more likely to
get preventive care
(mammogram) than control
arm (RR = 1.41; 95% Ci:
1.30-1.54)

Strengths:
Double blind
study reminder
for overdue for
preventive
care
(mammogram)
Limits: Study
did not
evaluate if
reminder
letters were
effective if
signed by
another
healthcare
professional.

8
Warriner et
al., 2012.
CASP:
moderate
quality

To determine if
mailed reminder
with brochure
improved
preventive care
(osteoporosis
screening).
RCT.
N = 2997 women
age 65 and older

Mailed reminder letter
with brochure
explaining how to selfschedule a DXA
screen versus usual
care

DXA completion was
outcome. Intervention
group had 977
participants and usual
care (control group)
had 2020 participants

17.3% of intervention
group completed the DXA
scan compared to 5.2%
(control) (p < 0.0001)

Strength:
The study
supported
efforts at
patient
activation of
screening.
Limiter:
Study
conducted at
single
academic
health system.

9
Lipscomb et
al., 2020.
CASP=mode
rate quality

Identify
adherence to
preventive care
(mammogram)
screening
guidelines for
Breast Cancer
survivors and
Female firstdegree relatives
(FDRs) N = 95
eligible breast
cancer survivors.
N = 83 eligible
FDRs.
RCT.

High intensity:
brochure, phone
counseling, mailed
patient reminders,
communications with
PCP
Low intensity:
brochure only

Measurements were
taken at 3- and 12month f/u
questionnaires.

12-month mammograms at
low intensity group:
survivor group 24 subjects,
FDRs group 34; 12-month
mammograms at high
intensity group: survivor 30
subjects, FDRs 23
subjects.
High intensity had 60%
FDR increase in screening
at 12 months was 79.2%
and low intensity was
66.7% at 12 months.

Limiters: many
subjects were
ineligible and
dropped out.

Strengths:
Intensity group
was improved
in this study
from this
intervention.

10

Level VI Evidence
Black, 2014
Melnyk & FineoutOverhold tool: High
quality

To determine if
patient mailed
reminders increase
bone mineral
density screen
rates
N = 47 female
participants
EBP project

Mailed patient
reminder

Participants
participating in
bone mineral
density screening
in 12-week period
improved screening
from 17.07% to
31.40%

Larger population
from patients of
physicians was
87.23% and
patients of the NP
was 12.77%. (X2 =
9.824, p=.002)

Strength: This
intervention proved
to be a successful
EBP project.
Limits: within 12week period of 47
participants.

11

Level VII Evidence

CDC Client

--

Evidence based

To increase

(Patient) reminder

intervention to use

screening rates.

planning guide.

patient reminders

(2021).

(Letter, postcard,

--

--

--

--

email, text or phone
call) to prompt
patient screening.
Health Partners

--

Contact with

Increase

patients when

preventative

preventative

screening to detect

screenings are due

diseases earlier.

either by email,
social media, alerts
on insurances.

12
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Appendix F: Patient Reminder Letter

October 12,
[October
XX,2021
2021]

Dear [Pa ent First Name],
We want to help you stay a ve and keep your independent lifestyle. That's why it's important to know
your bone health. The U.S. Preven ve Services Task Force recommends screening for osteoporosis in
women 65 years and older. A bone density test helps determine if you have osteoporosis, a disease of
the bones. It measures the amount of calcium and other minerals in your bones. Bones that become less
dense become weaker and are more likely to break.
Our records show that it's me for you to have a bone density measurement test. It takes only a few
minutes, is painless and non-invasive. We can help you schedule a bone density test at a convenient
me for you. Simply call our o ce at (574) 848-4039. If you already had a bone density test, please
contact our o ce so we can update our records.
Screening for osteoporosis can help you get the treatment you need to reduce your risk of broken
bones, par larly hip fractures. Osteoporo c fractures can limit mobility, cause chronic pain and lead
to loss of independence and decreased quality of life.
Based on your screening results, your doctor can recommend medica on to support bone health. Your
provider also can help you id
ways to add calcium, vitamin D and exercise into your daily rou ne.
Please help us in our orts to take ac on for bone health on October 20, when we recognize World
Osteoporosis Day. It's an opportunity to raise awareness about the preven on, diagnosis and treatment
of the disease.
You can learn more about the risk of fracture by reviewing the enclosed osteoporosis risk checklist. It
gives you helpful informa on about factors that may
your bone density. Please contact our o ce
if you have ques ons or would like more informa on about osteoporosis.
Sincerely,
Daniel Berger, MD
Mackenzie Shireman, DNP
Kacy Davis, FNP

FAMILY MEDICINE | BRISTOL
304 E. Vistula Street
Bristol, IN 46507
GoshenHealth.com

t (574) 848-4039

f (574) 848-4076
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Appendix G: PowerPoint to key stakeholders at Family Practice Setting
10/19/21

Background

Increasing Osteoporosis screening in
women among 65 years of age and older
in the primary care setting

Reasons why screening does not happen

• “Silent” disease of the bone
• Impaired remodeling process
• Implications resulting from a fracture
• Conditions related to Osteoporosis
• Costs associated with diagnosis
• Economic burden

Kacy Davis, MSN, RN, FNP-C, FNP-BC
DNP Candidate 2022

• Many barriers : socioeconomic, hours available for
screening, providers may not be aware they have not
been screened
• Marketing stresses cancer screenings more often than
osteoporosis screenings

”I have neither given or received, nor tolerated others’ use of unauthorized aid.”

1

2

3

Purpose

Statistics
October 12,
[October
XX,2021
2021]

Dear [Pa ent First Name],

• To increase Osteoporosis screening among women aged 65 and
older
• PICOT: Among women ages 65 and older, what is the effect of
patient mailed reminders on osteoporosis screening rates via
Dexa scan, as compared to previous screening rates over a 12week time period?
• Start time will be on October 20 correlating with National
Osteoporosis Day
• Patient mailed reminders will be sent out today (10/14/21)

We want to help you stay a ve and keep your independent lifestyle. That's why it's important to know
your bone health. The U.S. Preven ve Services Task Force recommends screening for osteoporosis in
women 65 years and older. A bone density test helps determine if you have osteoporosis, a disease of
the bones. It measures the amount of calcium and other minerals in your bones. Bones that become less
dense become weaker and are more likely to break.

• 61.1% who have had DEXA
• 104 out of 161 (MD)

• 64.6% with Dexa on EMR

• 17 out of 37 (NP)
• 45.9% with Dexa on EMR

• 38.9% who have not had DEXA
for both NP & MD

Our records show that it's me for you to have a bone density measurement test. It takes only a few
minutes, is painless and non-invasive. We can help you schedule a bone density test at a convenient
me for you. Simply call our o ce at (574) 848-4039. If you already had a bone density test, please
contact our o ce so we can update our records.
Screening for osteoporosis can help you get the treatment you need to reduce your risk of broken
bones, par larly hip fractures. Osteoporo c fractures can limit mobility, cause chronic pain and lead
to loss of independence and decreased quality of life.

• 57 out of the 161 (MD)

Based on your screening results, your doctor can recommend medica on to support bone health. Your
provider also can help you id
ways to add calcium, vitamin D and exercise into your daily rou ne.

• 20 out of 37 (NP)

You can learn more about the risk of fracture by reviewing the enclosed osteoporosis risk checklist. It
gives you helpful informa on about factors that may
your bone density. Please contact our o ce
if you have ques ons or would like more informa on about osteoporosis.

• 35.4% without Dexa on EMR

Please help us in our orts to take ac on for bone health on October 20, when we recognize World
Osteoporosis Day. It's an opportunity to raise awareness about the preven on, diagnosis and treatment
of the disease.

• 54% without Dexa on EMR

Sincerely,
Daniel Berger, MD
Mackenzie Shireman, DNP
Kacy Davis, FNP

FAMILY MEDICINE | BRISTOL
304 E. Vistula Street
Bristol, IN 46507
GoshenHealth.com

4

5

t (574) 848-4039

f (574) 848-4076

6

Conclusion
• Osteoporotic fracture rates are increasing
• Grade B recommendation that Dexa Scans should be performed
for women age 65 years and older per USPSTF
• Current screening rates in office can be higher
• This intervention serves to increase Osteoporosis screening
among this population within this family practice
• Evidence suggests mailed reminder may increase screening rates

7

1

